Information Provided By: 
Fly News Breaks for February 8, 2016
RARE
Feb 8, 2016 | 07:27 EDT
Canaccord said the recent selloff of Ultragenyx shares is overdone and would be buyers on the weakness. The firm believes a collaborator's weak guidance was conservative, which affected Ultragenyx, but they feel its pipeline will deliver steady positive data flow over the next few years. Canaccord reiterated its Buy rating and $126 price target on Ultragenyx shares.
News For RARE From the Last 2 Days
